CAR T-cell therapy demonstrates effectiveness in treating aggressive follicular lymphoma, providing durable responses after failed treatments, but needs further exploration as a primary treatment.
In a study of 130 relapsed follicular lymphoma patients, 95 responded to CAR T-cell therapy, with 92 achieving cancer remission, showing 81% in remission after one year.
Collection
[
|
...
]